BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device






 Company News
Celsion Corporation (CLSN) Announces Potent, Durable Preclinical Lung Expression Data For Its Novel TheraSilence RNA Program 5/21/2015 6:45:28 AM
Celsion Corporation (CLSN) Announces Publication Of Preclinical Data Demonstrating Lung Specific Delivery of microRNA-145 Inhibitor Using Its Novel TheraSilence Platform 5/15/2015 6:18:02 AM
Celsion Corporation (CLSN) Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results In Ovarian Cancer Presentation 5/14/2015 10:58:35 AM
Celsion Corporation (CLSN) Reports First Quarter 2015 Financial Results And Provides Business Update 5/12/2015 10:27:42 AM
Celsion Corporation (CLSN) To Hold First Quarter 2015 Financial Results Conference Call On Tuesday, May 12, 2015 5/5/2015 7:42:46 AM
Celsion Corporation (CLSN) Expands Clinical Development Plan For GEN-1 IL-12 Immunotherapy Program In Ovarian Cancer 4/29/2015 6:59:35 AM
Celsion Corporation (CLSN) Announces Appointment Of Harriet Shelare To Director, Communications 4/27/2015 7:40:33 AM
Celsion Corporation (CLSN) Announces Positive Interim Data From Its Phase 2 DIGNITY Study In Breast Cancer 4/15/2015 7:44:23 AM
Celsion Corporation (CLSN) Reports Year End 2014 Financial Results And Provides Business Update 3/12/2015 11:07:57 AM
Celsion Corporation (CLSN) To Hold Year-End 2014 Financial Results Conference Call On Thursday, March 12, 2015 3/5/2015 10:31:35 AM
12345678910...